HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Cuenca-López Selected Research

HLA-B18 Antigen

12/2017HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.
12/2017HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Cuenca-López Research Topics

Disease

2Liver Cirrhosis (Hepatic Cirrhosis)
12/2017 - 12/2017
1Fibrosis (Cirrhosis)
12/2017

Drug/Important Bio-Agent (IBA)

2HLA-B18 AntigenIBA
12/2017 - 12/2017
1HLA-B Antigens (HLA-B)IBA
12/2017

Therapy/Procedure

1Therapeutics
12/2017